Whitepapers
This Stream includes all of our Whitepapers Flipbooks
-
Read FlipbookWCG_BioOversightGeneResearch_White Paper_Final_July2019
-
Read FlipbookThe Most Important Voice Is Missing: The Case For Including Patient Insights In Protocol Design
-
Read FlipbookSomething Has to Give: The Current Unsustainable Approach to Safety Reporting Puts Trials and Patients at Risk
Something Has to Give: The Current Unsustainable Approach to Safety Reporting Puts Trials and Patients at Risk
-
Read FlipbookThe Power to Pivot: Decoding CNS Trials with Data Analytics
In this interview, Jesse Kooker, MPH, VP of Clinical Data Sciences at WCG's MedAvante-ProPhase, looks at the clinical development industry through the lens of data analytics.
-
Read Flipbook
Site-specific, Patient-centered and Whip-smart: Enrollment Assistants Adapt to a Shifting Landscape
-
Read FlipbookCompensating Participants in Clinical Research: Current Thinking
-
Benchmark your study enrollment versus competitors
Get Benchmark Data -
Read Flipbook
Virtual Clinical Trials Best Practices
-
Read FlipbookRecommendations for Study Sponsors on Informed Consent Documents
-
Read Flipbook
Invert to Convert: Rethinking Patient Recruitment and Enrollment Strategies
-
Read FlipbookLooking Ahead in 2019 Whitepaper
In this paper, 17 WCG thought-leaders provide insights on what they anticipate in 2019 in clinical trial technology, regulatory changes, and scientific developments.
-
Read FlipbookAddressing Suggestibility as a Psychological Phenomenon in Clinical Trials
It is important to understand patient perspectives and to anticipate how subjects in research studies may be impacted by the presence of digital tools, devices, and mobile health applications
-
Read Flipbook
Removing Barriers: Reimbursement and Compensation for Participation in Oncology Clinical Trials
The impact of participant payments on clinical trial recruitment.
-
Read Flipbook
Finding New Solutions to a Current Unsustainable Model of Clinical Trial Contracts & Budgets
-
Read Flipbook
Genetic Counselors at the Forefront of Helping Researchers Brace for the "Silver Tsunami" of CNS Disorders
An aging population is triggering a “silver tsunami” of neurodegenerative diseases like Alzheimer’s and Parkinson. At the same time, precision medicine holds great promise for many CNS disorders.
-
Read FlipbookDrug Safety Executive Summary eBook
-
Read Flipbook
Precision Medicine: A Glossary of Terms
As genetic testing becomes an integral part of clinical development programs, understanding the key terms and definitions is essential for all members of research and clinical development teams.
-
Read Flipbook
Returning Study Results to Research Participants
Studies show clinical trial participants want to know what was learned from their involvement. Many sponsors are implementing plans to deliver plain language summaries to trial participants.
-
Read Flipbook
Written Procedures for IRBs: What Does the New Final Guidance from FDA and OHRP Mean to You?
-
Read Flipbook
Five Essential Considerations for Efficient Site Contracts and Payments
-
Read Flipbook
Innovation in Investigator Site Contracting
-
Loading More...
